Citations

Mayo Clinic

Showing 10 of 108599 citations.

Healthcare Resource Availability, Quality of Care, and Acute Ischemic Stroke Outcomes
O’Brien, Emily C. , Wu, Jingjing , Zhao, Xin , Schulte, Phillip J. , Fonarow, Gregg C. , Bhatt, Deepak L. , Hernandez, Adrian F. , Schwamm, Lee H. , Peterson, Eric D. , Smith, Eric Edward , Bhatt, Deepak L

Journal of the American Heart Association | February 4, 2017 | Volume: 6 | Issue: 2 | Pages: No page available

10.1161/jaha.116.003813 | PMID 28159820 Get It

Background Healthcare resources vary geographically, but associations between hospital‐based resources and acute stroke quality and outcomes remain unclear. Methods and Results Using Get With The Guidelines‐Stroke and Dartmouth Atlas of Health Care data, we examined associations between healthcare resource availability, stroke care, and outcomes. We categorized hospital referral regions with high‐, medium‐, or low‐resource levels based on the 2006 national per‐capita availability median of 6 relevant acute stroke care resources. Using multivariable logistic regression, we examined healthcare resource level and in‐hospital quality and outcomes. Of 1 480 308 admitted ischemic stroke patients (2006–2013), 28.8% were hospitalized in low‐, 44.4% in medium‐, and 26.9% in high‐resource hospital referral regions. Quality‐of‐care/timeliness metrics, adjusted length of stay, and in‐hospital mortality were similar across all resource levels. Conclusions Significant variation exists in regional availability of healthcare resources for acute ischemic stroke treatment, yet among Get With the Guidelines‐Stroke hospitals, quality of care and in‐hospital outcomes did not differ by regional resource availability.
Overlooked FANCD2 variant encodes a promising, portent tumor suppressor, and alternative polyadenylation contributes to its expression
Shen, Yihang , Zhang, Piyan , Panneerselvam, Jayabal, Che, Raymond , Fei, Peiwen, Han, Bing , Zhang, Jun , Yu, Kai

Oncotarget | February 3, 2017 | Volume: 8 | Issue: 14 | Pages: 22490-22500

10.18632/oncotarget.14989 | PMID 28157704 Get It

Tripartite motif–containing 28 bridges endothelial inflammation and angiogenic activity by retaining expression of TNFR‐1 and −2 and VEGFR2 in endothelial cells
Wang, Yinfang, Li, Jin‐Ping , Dai, Xiuqin, Liu, Youbin , Liu, Zongjun , Wang, Ying , Wang, Nanping , Zhang, Peng , Wang, Yinfang, Huang, Yitong Pepper , Wang, Ying

The FASEB Journal | February 3, 2017 | Volume: 31 | Issue: 5 | Pages: 2026-2036

10.1096/fj.201600988rr | PMID 28159803 Get It

ABSTRACT Angiogenesis and inflammation are regarded as important factors in the pathogenesis of chronic inflammation, cancer, and wound healing. Recent studies have supported prior evidence that common signaling pathways are involved in angiogenesis and inflammatory responses; however, key factors controlling both processes remain unclear. Although tripartite motif‐containing (TRIM)‐28 is known to have an immunosuppressive role in immune cells, its expression level and role in endothelial cells (ECs) are still unclear. In this study, we investigated the role of TRIM28 in inflammatory responses and angiogenic activity of ECs for the first time. We showed that TRIM28 is the most abundant TRIM family member and is localized in nuclei of ECs. Small interfering RNA‐mediated knockdown of TRIM28 strikingly suppressed expression of TNF receptor (TNFR)‐1 and −2, decreased TNFα‐induced phosphorylation of IKKα/β and IκBα and degradation of IκBα and nuclear translocation of p65, and suppressed basal level and TNF‐α‐induced expression of chemokines and adhesion molecules, including VCAM‐1, IL‐6, ICAM‐1, E‐selectin, and monocyte chemoattractant protein (MCP)‐1. Unexpectedly, IL‐8 was potentiated by TRIM28 knockdown in ECs in an NF‐κB‐inducing kinase–dependent manner. Meanwhile, knockdown of TRIM28 inhibited expression of VEGF receptor 2 and suppressed VEGF‐induced proliferation and tube formation by ECs. Finally, knockdown of TRIM28 suppressed recruitment of ECs in vivo in a murine synthetic basement membrane model. In summary, we found that TRIM28 acts as a central factor in controlling endothelial inflammatory responses and angiogenic activities by retaining expression of TNFR‐1 and −2 and VEGF receptor 2 in ECs.—Wang, Y., Li, J., Huang Y., Dai, X., Liu, Y., Liu, Z., Wang, Y., Wang, N., Zhang, P. Tripartite motif–containing 28 bridges endothelial inflammation and angiogenic activity by retaining expression of TNFR1 and −2 and VEGFR2 in endothelial cells. FASEB J. 31, 2026–2036 (2017). www.fasebj.org
Haemoglobin decline before coeliac disease diagnosis: a nationwide transfusion cohort study of 1.1 million blood donors
Ludvigsson, Jonas F. , Sjölander, Arvid , Hjalgrim, Henrik , Edgren, Gustaf , Murray, Joseph A.

Gut | February 3, 2017 | Volume: 66 | Issue: 11 | Pages: 2036-2037

10.1136/gutjnl-2016-313541 | PMID 28159837 Get It

Bevacizumab May Differentially Improve Ovarian Cancer Outcome in Patients with Proliferative and Mesenchymal Molecular Subtypes
Kommoss, Stefan , Winterhoff, Boris , Oberg, Ann L. , Konecny, Gottfried E. , Riska, Shaun M., Fan, Jian-Bing, April, Craig, Shridhar, Viji , Kommoss, Friedrich, Hilpert, Felix , Mahner, Sven� , Baumann, Klaus , Schroeder, W., Burges, Alexander , Canzler, Ulrich , Chien, Jeremy , Embleton-Thirsk, Andrew , Parmar, Mahesh , Kaplan, Richard , Perren, Timothy , Hartmann, Lynn C. , Goode, Ellen L. , Dowdy, Sean C. , Pfisterer, Jacobus , Wang, Chen , Maurer, Matthew J. , Bois, Andreas du , Chien, Jeremey , Kaplan, Richard

Clinical Cancer Research | February 3, 2017 | Volume: 23 | Issue: 14 | Pages: 3794-3801

10.1158/1078-0432.ccr-16-2196 | PMID 28159814 Get It

Abstract Purpose: Recent progress in understanding the molecular biology of epithelial ovarian cancer has not yet translated into individualized treatment for these women or improvements in their disease outcome. Gene expression has been utilized to identify distinct molecular subtypes, but there have been no reports investigating whether or not molecular subtyping is predictive of response to bevacizumab in ovarian cancer. Experimental Design: DASL gene expression arrays were performed on FFPE tissue from patients enrolled on the ICON7 trial. Patients were stratified into four TCGA molecular subtypes. Associations between molecular subtype and the efficacy of randomly assigned therapy with bevacizumab were assessed. Results: Molecular subtypes were assigned as follows: 122 immunoreactive (34%), 96 proliferative (27%), 73 differentiated (20%), and 68 mesenchymal (19%). In univariate analysis patients with tumors of proliferative subtype obtained the greatest benefit from bevacizumab with a median PFS improvement of 10.1 months [HR, 0.55 (95% CI, 0.34–0.90), P = 0.016]. For the mesenchymal subtype, bevacizumab conferred a nonsignificant improvement in PFS of 8.2 months [HR 0.78 (95% CI, 0.44–1.40), P = 0.41]. Bevacizumab conferred modest improvements in PFS for patients with immunoreactive subtype (3.8 months; P = 0.08) or differentiated subtype (3.7 months; P = 0.61). Multivariate analysis demonstrated significant PFS improvement in proliferative subtype patients only [HR, 0.45 (95% CI, 0.27–0.74), P = 0.0015]. Conclusions: Ovarian carcinoma molecular subtypes with the poorest survival (proliferative and mesenchymal) derive a comparably greater benefit from treatment that includes bevacizumab. Validation of our findings in an independent cohort could enable the use of bevacizumab for those patients most likely to benefit, thereby reducing side effects and healthcare cost. Clin Cancer Res; 23(14); 3794–801. ©2017 AACR.
Increased cytoplasmic TDP-43 reduces global protein synthesis by interacting with RACK1 on polyribosomes
Russo, Arianna, Scardigli, Raffaella , Regina, Federico La, Murray, Melissa E. , Ceci, Marcello , Romano, Nicla , Dickson, Dennis W. , Wolozin, Benjamin , Cattaneo, Antonino , Murray, Melissa E

Human Molecular Genetics | February 3, 2017 | Volume: 26 | Issue: 8 | Pages: 1407-1418

10.1093/hmg/ddx035 | PMID 28158562 Get It

iPads for Patients: Sharing Authoritative Health Care Resources
Almader‐Douglas, Diana , Attwood, Carol Ann, Marks, Lisa , Pettenati, Nicole , Marks, Lisa A

Journal of Hospital Librarianship | February 3, 2017 | Volume: 17 | Issue: 1 | Pages: 71-79

10.1080/15323269.2017.1259448 Get It

Community Stakeholders’ Perceptions of the Role of Family in HIV Prevention in Iringa, Tanzania
Eustace, Rosemary W. , Wilson, Josephine F., Asiedu, Gladys B. , Nyamhanga, Tumaini , Mkanta, William N.

Journal of Community Health Nursing | February 3, 2017 | Volume: 34 | Issue: 1 | Pages: 10-20

10.1080/07370016.2017.1260981 | PMID 28156144 Get It

Medication Overuse Headache: Pathophysiological Insights from Structural and Functional Brain MRI Research
Chong, Catherine D. , Schwedt, Todd J. , Chong, Catherine D

Headache: The Journal of Head and Face Pain | February 3, 2017 | Volume: 57 | Issue: 7 | Pages: 1173-1178

10.1111/head.13037 | PMID 28160280 Get It

Background Research imaging of brain structure and function has helped to elucidate the pathophysiology of medication overuse headache (MOH). Methods This is a narrative review of imaging research studies that have investigated brain structural and functional alterations associated with MOH. Studies included in this review have investigated abnormal structure and function of pain processing regions in people with MOH, functional patterns that might predispose individuals to development of MOH, similarity of brain functional patterns in patients with MOH to those found in people with addiction, brain structure that could predict headache improvement following discontinuation of the overused medication, and changes in brain structure and function after discontinuation of medication overuse. Results and Conclusions MOH is associated with atypical structure and function of brain regions responsible for pain processing as well as brain regions that are commonly implicated in addiction. Several studies have shown “normalization” of structure and function in pain processing regions following discontinuation of the overused medication and resolution of MOH. However, some of the abnormalities in regions also implicated in addiction tend to persist following discontinuation of the overused medication, suggesting that they are a brain trait that predisposes certain individuals to medication overuse and MOH.
AUA White Paper on Nonneurogenic Chronic Urinary Retention: Consensus Definition, Treatment Algorithm, and Outcome End Points
Stoffel, John T. , Peterson, Andrew C. , Sandhu, Jaspreet S. , Wei, John T., Lightner, Deborah J., Suskind, Anne M. , Stoffel, John T

Journal of Urology | February 3, 2017 | Volume: 198 | Issue: 1 | Pages: 153-160

10.1016/j.juro.2017.01.075 | PMID 28163030 Get It